4.6 Review

AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease

Cheng-Kai Huang et al.

CIRCULATION RESEARCH (2020)

Article Biochemistry & Molecular Biology

miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury

Johanna Christine Jansing et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Immunology

TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib

Dandan Wu et al.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Review Biochemistry & Molecular Biology

Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models

Giuseppe Murdaca et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Pharmacology & Pharmacy

Therapeutic Oligonucleotides: State of the Art

C. I. Edvard Smith et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)

Article Cell Biology

Acute downregulation of miR-199a attenuates sepsis-induced acute lung injury by targeting SIRT1

Yang Liu et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)

Article Infectious Diseases

Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection

Christian Drosten et al.

LANCET INFECTIOUS DISEASES (2013)

Article Medicine, General & Internal

Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome

TWK Lew et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)